We have verified the hypothesis that multiple myeloma (MM) may be disseminated by circulating clonogenic cells that selectively home to the bone marrow (BM) to receive the signal(s) leading to proliferation, terminal differentiation, and production of the osteoclast activating factors. Long-term cultures of stromal cells have been developed from the BM of nine patients with MM. These cells were mostly fibroblastlike elements, interspersed with a proportion of scattered macrophages and rare osteoclasts. BM stromal cells were CD54+, produced high levels of interleukin-6 (IL-6) and measurable amounts of IL-le, and were used as feeder layers for ULTIPLE MYELOMA (MM) is a human B-cell M neoplasm characterized by the bone marrow (BM) accumulation of plasma cells that secrete monoclonal immunoglobulins (Ig) and by multiple osteolytic lesions.',2 The disease is widespread to the skeleton from the earliest recognizable stage, but very few plasma cells are seen in the peripheral blood (PB), where they can easily be appreciated only in the terminal phases of the disease.' This observation has suggested that human MM, like murine pla~macytoma,~ may be disseminated by clonogenic cells circulating in the PB.'.' Such a possibility is favored by different lines of evidence, including the presence of circulating B lymphocytes that express the relevant idiotypey the detection of a monoclonal Ig gene rearrangement within PB mononuclear cells (PBMC); and the identification of DNA-aneuploid cells in PB samples.' Also, plasma cell colonies may be grown from PB' and patients' PBMC may be induced to plasma cell differentiation by the synergistic activity of interleukin-6 (IL-6) and If MM clonogenic cells circulate, they must have the remarkable ability of selectively homing to the BM. In this environment they would receive the signal(s) leading to proliferation, terminal differentiation, and production of the osteoclast activating factors (OAF) that recruit osteoclasts and generate in situ osteolytic lesion^.^^^ To verify this hypothesis, we focused our attention on the BM-inductive microenvironment that regulates the differentiation and proliferation of lymphohematopoietic prec~rsors.'~~'~ Longterm cultures of stromal cells actively producing IL-6 were developed from the BM of MM patients and were used as feeder layers for autologous PBMC. In this experimental system, monoclonal B lymphocytes and plasma cells, derived from PBMC, as well as osteoclasts developed. Both populations grew tightly adherent to the stromal cell layer and their expansion was matched by a sharp increase of IL-6 and by the appearance of IL-3 in the culture supernatant. These data attribute to BM stromal cells a critical role in supporting the growth of B lymphocytes, plasma cells, and osteoclasts and the in vivo dissemination of MM.
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feeder layers for autologous PBMC. In this experimental system, monoclonal B lymphocytes and plasma cells, derived from PBMC, as well as osteoclasts developed. Both populations grew tightly adherent to the stromal cell layer and their expansion was matched by a sharp increase of IL-6 and by the appearance of IL-3 in the culture supernatant. These data attribute to BM stromal cells a critical role in supporting the growth of B lymphocytes, plasma cells, and osteoclasts and the in vivo dissemination of MM.
PATIENTS
Nine patients with MM, three men and six women, age 48 to 72, and four patients with monoclonal gammopathy of unknown significance (MGUS), two men and two women, age 50 to 71, were studied. MM patients ( Table 1) were classified according to Durie and Sa1m0n .l~ Five MM cases were studied at diagnosis, before the initiation of treatment; two who were unresponsive to therapy with Melphalan and prednisone, before starting aggressive chemotherapy; two who were partially responsive to therapy with Melphalan and prednisone, after six cycles of chemotherapy. The MGUS patients studied had a mean follow-up of 5 years. In each patient a BM aspirate and PB samples were concomitantly obtained after informed consent.
MATERIALS AND METHODS
Cells. BM nucleated cells were separated on methylcellulose, washed twice with phosphate-buffered saline (PBS), and cultured immediately. PBMC were separated on Ficoll-Hypaque and frozen in liquid nitrogen. Serum samples were stored at -80°C.
BM cells were resuspended in Dulbecco medium and 5% horse serum (HS), layered onto coverslips in 24-well culture plates at the concentration of 2 x lo6 cellslml, and cultured at 37°C in 5% CO,. Every 4 days half of the spent medium was replaced with an equal amount of fresh one. Myeloid and lymphoid cells either did not adhere or progressively detached and were thus removed. A confluent layer of adherent cells was observed after 5 to 7 weeks of culture of MM samples and allowed an experimental plan based on two different steps. First, adherent cells were characterized as for the morphology, phenotype, and cytokine production. Second, when no residual lymphocytes or plasma cells could be identified by staining coverslips with CD19, CD3, anti-y, p, a, K, A antibodies (Abs; see below) and no Ig could be found in the culture supernatant, autologous PBMC (2 x lo6/ mL) were thawed, washed twice with PBS, and seeded over the stromal cell layer. performed for 3 weeks at 37°C in 5% CO,, supplementing the medium with 20% fetal calf serum (FCS) and replacing every 4 days half of the spent medium with an equal amount of fresh one. The 3-week period was arbitrarily selected to give the putative circulating precursors enough time to develop and become detectable. After 3 weeks of coculture, coverslip-adherent cells were processed for the morphology and phenotype. The cells freely floating in the medium were harvested, cytocentrifuged, and likewise characterized. The cytokines present in the culture supernatant were measured. The following culture controls were performed: (1) BM cell cultures were prolonged for up to 14 weeks in presence of HS without adding autologous PBMC, (2) after the first 7 weeks, BM cell cultures were switched from HS to autologous serum (AS; 5% to 20%) or FCS (20%) without adding PBMC; and molecule; and rabbit Abs to factor VI11 (Behringwerke, Germany), which detects the factor VIII-related antigen, were added to the range. MoAbs were used in indirect IF as culture supernatants at 1:5 dilution or as purified ascitic fluid proteins (1 mg/mL at 1:1,000 final dilution) and shown by rabbit-antimouse-Ig conjugated with fluorescein isothiocyanate (FITC; Dakopatts, Cat. no. F 261) as previously described.I6 Slides were viewed in a Zeiss (Oberkochen, Germany) Axiophot epifluorescence microscope equipped with a planapochromat 63 x / 1.4 oil immersion lens.
The cytoskeleton organization of F-actin, which has a distinct distribution pattern in fibroblasts, macrophages, lymphocytes, and osteoclasts, was studied on coverslip-attached cells. Coverslips were fixed with 3% formaldehyde, stained as describedI6 with rhodamine-labeled phalloidin (R-PHD; Sigma Chemicals, St Louis,
Characterization of cultured cells.
MO, Cat. N. P 5157), which selectively binds to F-actin, and directly observed in the fluorescence microscope.
To identify the presence of calcitonin receptors, parallel cultures were incubated with '=I-calcitonin (specific activity 2,000 CiimM; Amersham, Bucks, UK) for 30 minutes, fixed as above, and dipped in llford K5 emulsion. Coverslips were exposed in the dark for 3 weeks, developed in Microdol-X Kodak (Milan, Italy) at 18°C for 5 minutes and fixed in Na,S,O, 30% in H,O for 10 minutes. Autoradiographs were stained with Giemsa and photographed either in light field or in dark field using an Antiflex 63x interference reflection lens attached to a Zeiss Axiophot photomicroscope.
IL-1 p and IL-6 levels were measured with ELISA (Genzyme, Boston, MA) following the manufacturer's instructions. IL-3 levels were measured with a biologic assay using the megakaryoblastic M-07 cell line," whose proliferation is IL-3 or 'granulocyte-macrophage colony-stimulating factor (GM-CSF) dependent. In the absence of IL-3 or GM-CSF, cells stop growing within 28 hours; after readdition of the growth factor, DNA synthesis is restored and the peak of proliferative activity is reached 24 hours thereafter. To perform the biologic assay, stock M-07 cells grown in 1 to 5 ng/mL IL-3 were thoroughly washed to remove growth factors and grown at the concentration of 1.5 x 106/mL in Iscove modified Dulbecco's medium (IMDM; GIBCO Europe, Paisley, Scotland) with 5% FCS at 37°C and 5% CO,. After 28 hours, 5 x 10' cells were resuspended in IMDM medium + 5% FCS and seeded in 200-kL wells in presence or absence of IL-3 (Genzyme). After 24 hours of incubation 1 p,Ci of 3H-TdR/well (specific activity: 5 CUmmoVL; Amersham) was added for additional 4 hours and the growth response of M-07 cells was used to design an IL-3 titration curve: the smallest amount of IL-3 that induced proliferation was 0.1 U/mL and the plateau was reached with 2 UlmL. Sera and culture supernatants were added to the cultures instead of IL-3 at 10% concentration, after 2 hours of preincubation at 37°C with 10 pg/mL anti-IL-3 neutralizing Ab (British Bio-technology Ltd, Cowley, Oxford, UK).
Cytokineproduction.

RESULTS
Characterization of MM BM stromal cells. BM adherent cells were mostly CD54 (ICAM-1)+ fibroblast-like cells (Fig  la) interspersed with a proportion of 10% to 15% scattered macrophages; no endothelial cells were found on the basis of von Willebrand factor immunoreactivity. Few large multinucleated cells (Fig lb) were scattered within the culture; these cells were positively stained with the TRAP reaction, organized cytoskeletal F-actin in podosomes located at the periphery (Fig la, at arrow) and displayed receptors for calcitonin (Fig IC) thus fulfilling the major criteria for identifying Few calcitoninpositive, podosome-bearing mononuclear cells were also found interspersed with larger cells. The stromal cell features and relative proportions were unmodified by prolonging the cultures for up to 14 weeks; also, the addition of AS (5% to 20%) and the substitution of HS with FCS after the first 7 weeks of culture did not lead to the appearance of lymphoid cells or increase the number of osteoclasts. In the supernatant of 7-week BM stromal cell cultures high levels of IL-6 and low levels of IL-1p were found, while IL-3 was undetectable ( Table 2) .
Characterization of BM-PBMC cocultures. The proportion of plasma cells among PBMC was 0.03% to 0.5% and the percentage of CD19' B cells was 3% to 6%. After 3 weeks of coculture the morphology showed that two series of events had taken place: (1) variable proportions of lymphoid cells and plasmacells (Fig 2) were interspersed with and tightly adhercnt to the CD54' stromal cell layer and (2) the number of stromal cell-bound giant multinucleatcd cells had significantly increased (Fig 3) . These findings wcrc ohservcd in all nine samplcs studied, irrcspectivc of thc Ig isotypc or thc stagc of thc disease. The lymphoid cells and plasma cells cxpresscd in each case the samc light chain produccd by BM malignant plasma cclls (Fig 2h) . (A) Sera from the patients whose stromal cell cultures were studied for the production of Ils: (B) BM stromal cell culture supernatants (7 weeks); (C) supernatants from 3-wwk-old cocultures between PBMC and autologous EM stromal cells. The data are the mean of experiments performed in triplicate (IL-6 and IL-10) or in quintuplicate (IL-3).
Abbreviations: U, undetectable; ND, not done. *Numben referred to patients detailed in Table 1 . tThe levels of monoclonal IgG were measured in the culture supemetants with ELI%: in (B) they were undetectable, in (C) fhey increased to 9.0 m@dL (case 7) and 12.7 mg/dL (case 9). For and plasma cclls wcrc always admixed with thc stromal cell laycr and were not found in the culturc supernatant, whcrc instcad, Tcells were floating together with variablc (10% to 30%) percentages of macrophages. A proportion of 15% to 40% T cclls rcactcd with CD2S and HLA-DR Abs, thus proving thcir state of activation. Thc numbcr of TRAP+ giant multinuclcatcd cclls cxprcsing thc calcitonin rcccp tor and cxhibiting thc cytoskclcton organization of ostcoclasts was significantly incrcascd in all samplcs (Fig 3) . IL-3 bccamc mcasurablc and IL-6 lcvcls wcrc incrcascd in the supcmatant of 3-wcck-old coculturcs, whilc IL-If3 lcvcls wcrc unchangcd ( Table 2) .
Control cxpcrimcnts pcrformed with coculturcs of BM cells and PBMC of four paticnts with MGUS showcd no obvious cnrichmcnt in plasma cells and ostcoclasts. Also, the growth and survival of stromal cells was grcatly reduced and IL-6 was undctcctablc.
DISCUSSION
In this work wc havc developed long-tcrm cultures of stromal cclls from thc BM of MM paticnts. The cell populations growing in culturc includc fibroblasts, macrophages, and bona fidc ostcoclasts, arc CDS4'. and producc high lcvcls of IM. Thc addition of PBMC to autologous BM stromal cclls supportcd thc growth and final diffcrcntiation of malignant B cells of peripheral origin and furthcr promotcd thc growth of ostcoclasts. B cclls and osteoclasts wcrc tightly adhcrcnt to the stromal cell laycr and thcir cxpansion was matched by an incrcased production of IL-6 and 1L-3. Thcsc cvcnts havc not bccn obscrvcd in MGUS.
Thc significancc of this work is thrccfold. First, it dcmonstratcs that clonogcnic cclls circulatc in the PB of MM paticnts and display thcir potential when brought in closc contact with IL-&producing BM stromal cclls. IL-6 has a potent MM growth promoting activity"'" and its production by BM stromal cells lcnds furthcr credit to thc possibility of a paracrinc regulation of MM cell growth."
Thc sccond point is the fcasibility of cultivating in vitro human osteoclasts from the BM of MM paticnts. The giant cells that wc havc grown in vitro satistj thc morphologic, cytochemical, and phcnotypic criteria of ostcoclasts, including thc peculiar cytoskclcton organization and thc prcscncc of calcitonin rcccptors.'K" Expcrimcnts with coverslips rcplaccd by bone slices arc currcntly underway to dcfinc thcsc cclls also in functional tcrms. The numbcr of ostcoclasts significantly incrcascd whcn PBMC wcrc addcd to thc stromal cell laycr, whilc it was unmodified by thc mcrc addition of FCS or AS. This incrcasc may bc duc to a rccruitmcnt of circulating osteoclast precursors or to the addition of cytokinc-producing cclls facilitating the in situ prolifcration of ostcoclasts or favoring thc diffcrcntiation of For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From osteoclast precursors growing within the BM stromal cell layer.
Finally, our findings point out the network of cells and cytokines that may operate in the dissemination of the disease. The role of some cytokines in the growth of MM B-lineage cells and osteoclasts has already been stressed and led us to concentrate upon IL-lp, IL-3, and IL-6. Besides IL-6,2"M IL-3 also may be involved in the proliferation of MM and IL-1p is able to accelerate the growth of MM cells through IL-6.32 Further, IL-lp,33,34 IL-3,35 and IL-6" have an OAF activity. We have observed that BM stromal cells produce IL-lp and high amounts of IL-6 ( Table 2) ; when PBMC are added to autologous stromal cell cultures, IL-6 levels are increased and measurable amounts of IL-3 appear in the culture supernatants. These findings suggest a role for activated T cells of PB origin that might release IL-337 and contribute to the production of IL-6.38
In conclusion, our findings attribute to BM stromal cells a critical role in favouring the growth and dissemination of MM. Conceivably, the culture system used in these experiments may be used to identify MM circulating clonogenic cells, to investigate the kinetics of development of B-lineage cells, and to characterize the paracrine milieu operating in the disease, thereby defining the immunoregulatory circuits amenable to therapeutic manipulation.
